Who owns CENTURY THERAPEUTICS INC?
- Ticker: IPSC
- CUSIP Number: 15673t100
Tip: Access positions for across all investors
Analyze quarterly positions in Century Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Century Therapeutics stock
Who bought or sold CENTURY THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Point72 Asset Management | 6.0M | $5.9M | 100% | Dec 2025 |
|
| DAFNA Capital Management | 2.8M | $2.8M | 64% | Dec 2025 |
|
| Vanguard Group | 2.1M | $2.1M | 0% | Dec 2025 |
|
| Adage Capital Partners GP | 1.8M | $1.8M | 100% | Dec 2025 |
|
| Two Sigma Investments | 1.5M | $1.5M | 64% | Dec 2025 |
|
| Renaissance Technologies | 1.3M | $1.3M | -48% | Dec 2025 |
|
| Two Sigma Advisers | 1.3M | $1.3M | 48% | Dec 2025 |
|
| Casdin Capital | 1.2M | $1.2M | 0% | Dec 2025 |
|
| Acadian Asset Management | 1.2M | $1.2M | 69% | Dec 2025 |
|
| Syncona Portfolio | 1.2M | $1.2B | 0% | Dec 2025 |
|
| Millennium Management | 610k | $607k | -18% | Dec 2025 |
|
| BlackRock | 602k | $599k | 0% | Dec 2025 |
|
| Superstring Capital Management | 463k | $461k | 0% | Dec 2025 |
|
| Geode Capital Management | 456k | $454k | 2% | Dec 2025 |
|
| GSA Capital Partners | 333k | $331k | -45% | Dec 2025 |
|
| Citadel Advisors | 320k | $318k | -11% | Dec 2025 |
|
| UBS Group | 215k | $213k | 63550% | Dec 2025 |
|
| State Street Corporation | 127k | $127k | 0% | Dec 2025 |
|
| Northern Trust | 105k | $105k | 57% | Dec 2025 |
|
| Raymond James Financial | 91k | $91k | 0% | Dec 2025 |
|
| Algert Coldiron Investors | 77k | $76k | 100% | Dec 2025 |
|
| FMR | 72k | $71k | -63% | Dec 2025 |
|
| Prudential Financial | 60k | $60k | 0% | Dec 2025 |
|
| Susquehanna International | 50k | $50k | -26% | Dec 2025 |
|
| Cannon Global Investment Management | 49k | $111k | 100% | Mar 2026 |
|
| Jane Street | 45k | $45k | -23% | Dec 2025 |
|
| HarbourVest Partners | 29k | $29k | 0% | Dec 2025 |
|
| Parametrica Management | 28k | $28k | 0% | Dec 2025 |
|
| XTX Topco | 15k | $15k | -44% | Dec 2025 |
|
| Quadrant Private Wealth Management | 15k | $15k | 0% | Dec 2025 |
|
| Scientech Research | 12k | $12k | 100% | Dec 2025 |
|
| Advisors Asset Management | 8.3k | $8.3k | -1% | Dec 2025 |
|
| Farther Finance Advisors | 2.5k | $5.5k | 100% | Mar 2026 |
|
| Simplex Trading | 2.4k | $2.4k | 100% | Dec 2025 |
|
| SBI Securities | 1.5k | $1.5k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $1.4k | -2% | Dec 2025 |
|
| NISA Investment Advisors | 883.00 | $877.966900 | 0% | Dec 2025 |
|
| Mark Sheptoff Financial Planning | 500.00 | $497.000000 | 0% | Dec 2025 |
|
| Fortitude Family Office | 294.00 | $663.999000 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 99.00 | $98.000100 | 0% | Dec 2025 |
|
| Wells Fargo & Company | 40.00 | $40.000000 | 100% | Dec 2025 |
|
| Optiver Holding B.V. | 32.00 | $32.000000 | 0% | Dec 2025 |
|
| Smartleaf Asset Management | 1.00 | $1.000000 | 100% | Dec 2025 |
|
| Barclays | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Century Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bain Capital Life Sciences Investors | Sep 2025 | 3.5M | $1.8M |
| Tang Capital Management | Sep 2025 | 900k | $448k |
| Squarepoint Ops | Sep 2025 | 236k | $118k |
| Wealth Enhancement Advisory Services | Dec 2025 | 78k | $70k |
| Goldman Sachs Group | Sep 2025 | 61k | $30k |
| Marshall Wace | Sep 2025 | 54k | $27k |
| Hrt Financial | Sep 2025 | 18k | $9.0k |
| Qube Research & Technologies | Sep 2025 | 18k | $8.7k |
| Tower Research Capital | Sep 2025 | 13k | $6.5k |
| Jain Global | Sep 2025 | 11k | $5.6k |
| AQR Capital Management | Sep 2025 | 11k | $5.3k |
| Advisory Services Network | Sep 2025 | 407.00 | $203.011600 |
| CWM | Sep 2025 | 254.00 | $0 |
| EverSource Wealth Advisors | Sep 2025 | 28.00 | $14.000000 |